WEEKLY UPDATE
Jul 07
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  MDRD GFR
Slides/audio/handouts:    RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  :  ADC-2007(a)  :  RPA-2007(s/a)  :  RRI-2007(s/a/h)  : 
Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Worcester  

Lieske  

  Physicochemical Factors in the Pathogenesis of Urinary Calculi (Worcester); Nephrolithiasis: A Bacterial Disease? Evidence Supporting and Against a Role of Nanobacteria in Calcium Stone Formation (Lieske) Flash slide/audio
(ASN Clinical Nephrology Conference, November, 2007)
Worcester: What are the conditions for stone formation? How is supersaturation of urine for calcium phosphate and calcium oxalate involved? What is the optimum pH? Is urine alkalinization dangerous? Do meals affect calcification risk? How is calcium apatite plaque involved and which types of stones start in this way? What are present models of hypercalciuria? Is separation into hyperabsorbers and hyperexcretors useful? How can stone formation best be prevented? Lieske: What are nanobacteria? How small are they? What species are they related to? What types of calcification are they possibly linked to in the human body? In what types of biologic specimens can they be found? Is there any way that we can inhibit their growth? Which antibiotics seem to work? What to we know about their DNA? How can they be grown in culture?
(more...)


ASDIN  

  ASDIN Annual Meeting. February, 2008. Part Four. Flash slide/audio -- Free to ASDIN members

Review of the Anticoagulation Cascade: Heparin, Warfarin, t-PA
Kenneth Abreo, M.D

HIT and heparin alternatives in the access center
Aris Q. Urbanes M.D.

High-Output Cardiac Failure and Vascular Access
Monnie Wasse, MD, MPH

Venous Access in CKD patients
Jeffrey Hoggard, M.D.

Coding Updates
Donald Schon, MD, FACP AKDHC

(more...)


Hypertension, Cardiovascular
Resistant HTN guidelines (AHA)
Angiotensin II blockade in Marfan syndrome
Renin-angiontensin system and aging (review)
Gender differences in regression of LVH
Weight loss and endothelial function
CKD, ESRD
CAC and prediction of CV disease
For-profit vs. not-for-profit dialysis mortality
Rivaroxaban better than enoxaparin after surgery
Waist to hip ratio predicts CKD and death
Overweight, obesity, and CKD incidence
Ionic dialysance and Kt in dialysis
Super-flux membrane good to reduce beta-2
Recycling dialysis wastewater
Treating elderly diabetics with stage 3,4 CKD
Niacinamide for phosphate binding
Sevelamer carbonate for pre-ESRD patients
Epo responsiveness and mortality
Nonuremic calciphylaxis
Extended dosing regimens for EPO in CKD
EPO and endothelial synthesis of tetrahydrobiopterin
Altitude affects EPO sensitivity and response
Activated vitamin D and race on survival in HD
Daily dialysis in the ICU of no benefit
Clinical Nephrology
Rust urine after hand drumming
When to order an ionized calcium (key)
Oxalate in renal stone disease



ANNA CE

(Article Free, $CE)
ANNA CE (NNJ)
Target audience: Nurses. Article free, CE requires payment to ANNA via HDCN.

Knowledge Expectations of Patients On Dialysis Treatment
(Vol 35/No. 3. Expires 06/30/2010)
Mirkka Rantanen, MNSc, RDH; Tapio Kallio, MNSc, RN; Kirsi Johansson, PhD, RN; Sanna Salanter„, PhD, RN; Heli Virtanen, PhDc, MNSc, RN; Helena Leino-Kilpi, PhD, RN
1.5 hr

Pharmacotherapeutic Options for the Treatment of Depression in Patients With Chronic Kidney Disease
(Vol 35/No. 3. Expires 06/30/2010)
Colette B. Raymond, BScPharm, Pharm D, MSc, ACPR; Lori D. Wazny, BScPharm, Pharm D; Patricia L. Honcharik, BScPharm, Pharm D, ACPR
1.5 hr




ASN Renal Week 2007
now in MP3
AUDIOFILE LIST (Renal Week 2007)

2007 Renal Week PGE Course:

PGE: REACTIVE OXYGEN SPECIES (Part 2 of 2)

HIF-1a and Oxygen Sensing
Salvador Moncada, MD, PhD

Oxygen Sensing by the Pulmonary Vasculature
Stephen L. Archer, MD

Vascular Oxygen Sensing: Role of NADPH and Nox Oxidase
Michael S. Wolin, PhD

ROS: Activation of Signal Transduction
Henry Jay Forman, PhD

H2O2: Regulation of Protein Tyrosine Phosphatase
(Post-doctoral fellow)

Isoprostanes and Related Lipid Oxidation Products as Mediators and Markers of Oxidant Stress in Vivo
Jason D. Morrow, MD

Transgenic Approaches to Lipid and Protein Nitration Reactions in Inflammatory Processes
Bruce Freeman, PhD

H2O2 as an EDHF
David D. Gutterman, MD

Tetrahydrobiopterin and Vascular Dysfunction
Jeannette Vasquez-Vivar, PhD

Stress Dependent Regulation of FOXO Transcription Factors
Anne Brunet, PhD




    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: July 23, 2008 (J23)
J23 Texas ESRD Network hurricane resource site
J23 Hurricane Dolly now at south Texas coast.
J23 How bacterial biofilms use chemical weapons against amoebas
J23 Scientists isolate compound in saliva that speeds wound healing.
J22 Dr. Arnold Kim gives up nephrology practice to attend to his Mac blogging site and other projects.
J22 As travel costs rise, more meetings go virtual.
J22 House Appropriations Subcommittee increases proposed FDA budget by more than 20% to over 2 billion dollars per year.
J22 Vagal nerve stimulation suppresses spleen production of TNF: A brain to immune system connection?
J22 New type of chlorine-tolerant membranes developed for desalination.
J22 The cold, cruel facts?: Disease prevention programs may not lower costs in the long run?
J22 Ezetimibe plus simvastatin drug trial shows no effect on aortic valve stenosis progression.
J22 Prostate cancer drug abiraterone hailed as a breakthrough in the treatment of advanced disease.
J22 Ice-tea aficionado develops kidney stones
J22 Woman who claimed water-loading diet caused brain damage due to seizures wins lawsuit.
J21 Dr. Joseph Letteri, an expert in kidney treatment; in memoriam
J21 Advance lowers risk of rejection of animal tissues.
J21 Anti-bacterial actions of cranberry juice explained by its action on fimbriae.
J21 Adding calcium hydroxide to seawater may reverse global warming.
J21 Drug industry: No more free pens, pads, or mugs for docs.
J21 Singapore mulls legal kidney trading.
General Advances Emphasis
archive
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
Abaterusso and colleagues discuss the realities and practical approaches of treating CKD in the elderly; from the July issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

When is it appropriate to order an ionized calcium?
Calvi and Bushinsky discuss how ionized calcium measurement may be better than albumin-corrected calcium in a number of intensive care situations, and also in some ambulatory settings; from the July issue of the J Am Soc Nephrol (JASN) (more...)

Lipid abnormalities and cardiovascular risk in renal disease
Ritz and Wanner review the effects of CKD on lipids, the evidence that lipid control may slow progression, and suggest treatment regimens in this population; from the June issue of the J Am Soc Nephrol (JASN) (more...)

Role of remission clinics in the longitudinal treatment of CKD
What is a remission clinic for CKD patients, and what are the results in terms of progression when patients are aggressively monitored and treated in this way? Ruggenenti and colleagues tells us, in the June issue of the J Am Soc Nephrol (JASN) (more...)

Staging of chronic kidney disease: time for a course correction
Bauer et al tell us why the NKF KDOQI staging system is seriously flawed; from the May issue of the J Am Soc Nephrol (JASN) (more...)

Idiopathic membranous nephropathy: diagnosis and treatment
Fervenza and colleagues review the latest approach to idiopathic membranous nephropathy; from the May issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

High-molecular weight iron dextran: a wolf in sheep's clothing?
Rodgers et al describe patient allergic reactions in patients switched from low to higher MW dextrans by the pharmacy in order to save costs. from the May issue of the J Am Soc Nephrol (JASN) (more...)

Nephrogenic systemic fibrosis: early recognition and treatment
Knopp and Cowper review the very early signs of this disorder, and discuss criteria for diagnosis as well as etiology. from the April issue of Seminars in Dialysis. (more...)

Glucose in the dialysate: Historical perspective and possible implications?
Sharma and Rosner discuss this. Should we add glucose at all? If so, how much is too much, and how much is enough? from the April issue of Hemodialysis International. (more...)

Atherosclerotic renal artery stenosis: overtreated but underrated?
Textor reviews the latest in terms of diagnosis and treatment; this test; from the April issue of the J Am Soc Nephrol (JASN) (more...)

Trends in organ donation and transplantation in the United States, 1997-2006
Port and his colleagues document the trends in organ transplantation and transplantation up through 2006; in the April 2008 issue of the Am J Transplant. (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...









 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99